We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Epigenetics Optimized Cell Culture Conditions To Drive and Maintain Cell Identity
Industry Insight

Technology Networks spoke with Pierre-Louis Joffrin, corporate development officer at Mogrify, to learn more about the EpiMOGRIFY platform, the advantages of using a data-driven method to maintain cell identity and support cell conversion, and the implications this could have for the development of cell therapies.

Read More

3 Major Trends for Cardiac Drug Discovery in 2020
Industry Insight

Without a doubt, we will remember 2020 as the year of the COVID-19 pandemic. For the biopharma and healthcare sectors, the focus was firmly on the rapid development of diagnostics, therapies and vaccines that could be produced at scale. But under the radar, other life science fields have been powering on – among them, the cardiac field.

Read More

Planning for 2021: Three Lessons the Clinical Development Sector Can Learn From 2020
Industry Insight

The clinical trials industry, like many other global sectors, has been hit hard by the pandemic. One outcome has been the necessary diversion of resources to the development of COVID-19 vaccines and treatments alongside the care of critically ill patients. Impending economic contraction around the world means trials are also taking place against a backdrop of tighter budgets, leaving clinical development on a cliff edge as 2021 approaches.

Read More

Cell Replacement Therapy – A Promising Treatment for Age-Related Macular Degeneration
Industry Insight

Here we share a Q&A with Brian Culley, CEO of Lineage Cell Therapeutics. In this interview, Brian discusses age-related macular degeneration and retinal pigment epithelium transplant therapy.

Read More

Collaboration Is the Key to Efficient Product Development
Industry Insight

Outsourcing certain aspects of experimental work to biotech companies with vital experience in relevant areas can help to advance products more rapidly, accelerating time-to-market and ensuring success.

Read More

A Vaccine for Alzheimer’s Disease? An Interview With AC Immune’s Prof Andrea Pfeifer
Industry Insight

Swiss biopharma AC Immune has made targeting Alzheimer’s disease, the leading form of dementia, a top priority. 2020 has brought mixed news for AC Immune's therapeutics, including promising safety data for their anti-Alzheimer's disease vaccine candidate. To discuss AC Immune’s work, Technology Networks spoke to CEO Prof. Andrea Pfeifer.

Read More

Overcoming the Challenges of Manufacturing Therapeutic Mesenchymal Stem Cells
Industry Insight

Technology Networks had the pleasure of speaking with Ross Macdonald, CEO of Cynata Therapeutics, to learn more about the challenges of manufacturing therapeutic MSCs and how the Cymerus technology overcomes these.

Read More

Could DMT-Assisted Therapy Help Treat Mental Health Disorders?
Industry Insight

The role that psychedelic therapeutics could play in tackling many intractable mental health conditions has finally been recognized by mainstream medicine. To find out more, we spoke to Carol Routledge, Chief Medical & Scientific Officer at Small Pharma.

Read More

Ensuring Data Integrity Compliance in Pharma With CDS Software
Industry Insight

Data integrity is fundamental to drug development and manufacturing but can be difficult to achieve for drug developers and manufacturers who have to navigate strict data integrity guidelines provided by regulatory authorities and find effective ways to attain compliance.

Read More

Cell and Gene Therapy Manufacturing: Achieving Consistency and Reducing Variability
Industry Insight

Cell and gene therapies first gained regulatory approval in 2017 by the US Food and Drug Administration (FDA). Several more therapies have since been developed, and there are now 18 approved to treat a variety of diseases Technology Networks recently had the pleasure of speaking with experts at Bio-Techne to learn more about the cell and gene therapy manufacturing process.

Read More

 
Advertisement